Table 1.
Group | Compound | Effective Concentration | Experimental Model | Mode of Action | Reference |
---|---|---|---|---|---|
Phytochemicals–Polyphenols | |||||
Phenolic acid | Ellagic acid | 25–50 µM | Human keratinocyte HaCaT cells | ↑ Nrf2 nuclear translocation. ↑ SOD enzyme activity. |
[141] |
Chlorogenic acid | 100 µM | Human retinal pigment epithelial ARPE-19 cells | ↑ mRNA expression of Nrf2 and SOD. | [142] | |
500 mg/kg of body weight orally | Sprague-Dawley rats | ↑ mRNA expression of Nrf2. ↑ SOD and GSH activities. |
[143] | ||
Proanthocyanidin | Procyanidin C1 | 5–10 µM | Mouse hippocampal neuronal HT22 cells | ↑ Nrf2 nuclear translocation. ↑ HO-1 protein. |
[144] |
Lignans | Sesamin | 100 mg/kg body weight intraperitoneally | C57BL/6 mice | ↑ SOD and CAT activities. ↑ GSH and Nrf2 protein. |
[145] |
10 µM | Primary chondrocytes | ↑ Nrf2 and HO-1 proteins. | [146] | ||
Coumarins | Fraxin | 50 mg/kg of body weight up to 5 days orally | Sprague-Dawley rats | ↑ cellular GSH levels. | [147] |
Stilbene derivative | Resveratrol | 5 µM | Primary human coronary artery endothelial cells | ↑ mRNA expression of NQO1. | [148] |
500 mg in a tablet/day up to 30 days in the morning fasting | Phase 3 clinical trial on chronic subclinical inflammation and redox status | ↑ electrophilic modification of Keap1-Cys-151 | [47,85] | ||
215 mg in a tablet/day up to 52 weeks | Phase 2 clinical trials on Alzheimer’s disease | ↑ electrophilic modification of Keap1-Cys-151 | [47,149] | ||
Curcumminoid | Curcumin | 5 µM | Human extravillous trophoblast HTR8/Sveo cells | ↑ CAT and GSH activities. | [150] |
400 mg/kg body weight/day orally up to 21 days | White Pekin ducklings | ↑ CAT, SOD, and GPx activities. | [151] | ||
800 mg/day in two capsules up to 7 days | Phase 3 clinical on diabetic nephropathy | ↑ electrophilic modifications of Keap1-Cys-151 | [47,82] | ||
15 µM | Human retinal pigment epithelial ARPE-19 cells | ↑ Nrf2 protein. ↑ HO-1 activity. |
[152] | ||
15–30 µM | Porcine renal epithelial proximal tubule LLC PK1 cells | ↑ ARE binding activity. ↑ Nrf2 protein. ↑ HO-1 activity. |
[153] | ||
10 µM | Rat kidney epithelial NRK-52E cells | ↑ ARE binding activity. | [153] | ||
200 mg/kg body weight twice a week for 6 weeks | Kunming (KM) mice | ↑ Nrf2 nuclear translocation. ↑ HO-1 and NQO-1 proteins. |
[154] | ||
Phytochemicals–Polyphenols–Flavonoids | |||||
Flavone | Luteolin | 0.1 mg/kg body weight/day for 7 days at two time points orally. | ICR mice | ↑ Nrf2 nuclear translocation. ↑ HO-1 and NQO-1 proteins. |
[51] |
10 mg/kg body weight intracerebrally injected | Sprague-Dawley rats | ↑ Nrf2 nuclear translocation. ↑ HO-1 and NQO-1 proteins. |
[131] | ||
5–10 µM | Rat myoblast H9c2 cells | ↑ Nrf2 protein. ↑ mRNA expression of SOD, NQO-1 and HO-1. |
[93] | ||
5 µM | Mouse testis sertoli TM4 cells | ↑ Nrf2 nuclear translocation. | [121] | ||
3,5-di-O-Methyl Gossypetin | 10–25 µg/mL | Human keratinocyte HaCaT cells | ↑ Nrf2 nuclear translocation. ↑ GSH, SOD and HO-1 proteins. |
[55] | |
Baicalein | 160 mg/kg/day for 8 weeks orally | T2DM Kunming mice | ↑ Nrf2 nuclear translocation. ↑ SOD, CAT, GSH proteins. |
[120] | |
50 µM | Human liver L-02 cells | ↑ p62 protein. ↑ Nrf2 dissociation from Keap1. ↑ Nrf2 phosphorylation via phosphorylation of ERK1/2 and protein kinase C. |
[117] | ||
20 µM | Human liver HL-7702 cells | ↑ Nrf2 nuclear translocation. ↑ SOD, CAT, GSH protein. |
[120] | ||
Baicalin | 50 mg/kg body weight twice after 2 and 12 h of subarachnoid hemorrhage intraperitoneally. | Sprague-Dawley rats | ↑ SOD, GSH, NQO-1, and Nrf2 proteins. ↑ mRNA expression of HO-1. |
[94] | |
75 µM | Rat myoblast H9C2 cells | ↑ Nrf2 and HO-1 proteins. | [97] | ||
450 mg/kg body weight/day up to 7 days orally. | Chicken | ↑ Nrf2 and HO-1 proteins. ↑ mRNA expression of Nrf2 and HO-1. |
[116] | ||
50 µM | Human liver L-02 cells | ↑ p62 protein. ↑ Nrf2 dissociation from Keap1. ↑ Nrf2 phosphorylation via phosphorylation of ERK1/2 and protein kinase C. |
[117] | ||
Chrysin | 10–25 µM | Rat hepatocytes | ↑ Nrf2 nuclear translocation via ERK2 signaling. ↑cellular GSH protein. ↑ ARE binding ability. |
[124] | |
Apigenin | 400 µM | Human retinal pigment epithelial ARPE-19 cells | ↑ mRNA expression of Nrf2. ↑ Nrf2 protein. ↑ Nrf2 nuclear translocation. ↑SOD, CAT, and GPx activities. |
[95] | |
200 µM | Human renal tubular epithelial HK-2 cells | ↑ mRNA expression of Nrf2 and HO-1. ↑ Nrf2 protein. |
[100] | ||
Flavonol | Myricetin | 100 mg/kg/day for 6 weeks orally | Kungming mice | ↑ Nrf2 nuclear translocation. | [132] |
Quercetin | 30 µM | Human keratinocyte HaCaT and BJ foreskin fibroblast cells | ↑ Nrf2 protein. | [102] | |
200 mg/kg body weight/day for 20 days orally | Broiler chicken | ↑ Nrf2 protein. ↑ Nrf2 nuclear translocation. ↑ SOD and CAT proteins. |
[111] | ||
100 µM | Intestinal epithelial IEC-6 cells | ↑ Nrf2 nuclear translocation. | [155] | ||
10 µM | Human umbilical endothelial cells | ↑ Nrf2 protein. | [108] | ||
Rutin | 44 µM | Human keratinocyte HaCaT cells | ↑ mRNA expression of HO-1 and NQO-1. | [140] | |
Flavanone | Naringenin | 80 µM | Sprague-Dawley rat neuron cells | ↑ Nrf2, HO-1, and NQO-1 proteins. | [103] |
70 mg/kg body weight/day up to 4 days orally | C57BL/6 mice | ↑ Nrf2 protein. | [112] | ||
Hesperidin | 50 mg/kg body weight for 28 days orally | Sprague-Dawley rat | ↑ Nrf2 and HO-1 proteins. ↑ mRNA expression of HO-1. |
[104] | |
Flavan-3-ol | Epicatechin | 10–100 µM | Primary astrocytes from WT and Nrf2 deficient KO mice | ↑ Nrf2 nuclear translocation. | [122] |
Epigallocatechin-3-gallate (EGCG) |
40 mg/kg body weight/day for 3 days intraperitoneally or a single dose of 50 mg/kg body weight intraperitoneally | Sprague-Dawley rat | ↑ Nrf2 protein. | [105,156] | |
Isoflavones | Genistein | 1 mg/kg body weight intraperitoneally | Sprague-Dawley rat | ↑ Nrf2 nuclear translocation. ↑ HO-1 protein. |
[138] |
Anthocyanin | Cyanidin-3-O-glucoside (C3G) |
20–40 µM | Human umbilical vein epithelial cells | ↑ Nrf2 nuclear translocation. ↑mRNA expression of NQO-1 and HO-1. |
[128] |
Chalcone | Butein | 20 µM | Human dental pulp cells | ↑ Nrf2 nuclear translocation. | [130] |
Other Phytochemicals | |||||
Sulfur-containing | Sulforaphane | 5 µM | Mouse skin JB6 P+ cells | ↑ Nrf2 nuclear translocation. ↑ HO-1 and NQO-1 proteins. |
[157] |
Diallyl sulfide | 15 µM | Human embryonic lung MRC-5 cells | Dissociates Nrf2 from Keap1 through phosphorylated ERK and p38 interactions. ↑ Nrf2 nuclear translocation. |
[89] | |
150 mg/kg body weight/day intraperitoneally for 6 days | Wistar rats | ↑ Nrf2 protein. ↑SOD, CAT, GPx, GR, GST, and quinone reductase activities. |
[158] | ||
Alkaloids | Berberine | 200 mg/kg body weight/day orally for 16 weeks | Wistar rats | ↑ mRNA expression of Nrf2. | [159] |
Vitamins | |||||
Fat-soluble vitamins | Vitamin D | 40 000 U/kg/week of body weight intratracheally for 8 weeks | C57BL/6 mice | ↑ mRNA expression Aldo-keto reductase family 1 member C1 (AKR1C1) and GCLM. | [160] |
Vitamin E | 100 mg/kg body weight/day intraperitoneally for 6 days | Balb/c mice | ↑ Nrf2 and HO-1 protein levels. | [161] | |
Vitamin A | 100,000 U/kg body weight/day subcutaneously for 14 days | Wistar rats | ↑ Nrf2 nuclear translocation. ↑ HO-1 and NQO 1 proteins. |
[162] | |
Water-soluble vitamins | Vitamin C | 27–65 mg/kg body feed twice a day for 8 weeks | Juvenile Sillago sihama | ↑ mRNA expression of Nrf2, CAT, SOD, GPx, GR, and GST in intestine and liver cells. | [163] |
Vitamin B2 | 30 mg/kg body weight/day intra-gastrically | APP/PS1 double transgenic mice | ↑ SOD, CAT, GSH, and GPx activities. ↑ Nrf2 expression. ↓ Keap1 expression. |
[164,165] | |
Endogenous Signaling Molecules | |||||
Protein kinases | PI3K | N/A | Human retinal pigment epithelial RPE-19 cells | ↑ Nrf2 nuclear translocation. | [92] |
JNK 1 & 2 | N/A | Human embryonic kidney HEK 293T cells | Phosphorylates Nrf2 at S212, S408, S558, S577, and T559. | [80] | |
p38 | N/A | Human embryonic kidney HEK 293T cells | Phosphorylates Nrf2 at Ser212, Ser408, Ser558, Ser577, and Thre559. | [80] | |
AMPK | N/A | Human embryonic kidney HEK 293T cells | Phosphorylates Nrf2 at the Ser558 residue. ↑ Nrf2 nuclear translocation. |
[49] | |
ERK2 | N/A | Human embryonic kidney HEK 293T cells | Phosphorylates Nrf2 at Ser212, Ser408, Ser558, Ser577, and Thre559. | [80] | |
Casein kinase 2 | N/A | Human embryonic kidney HEK 293T cells | ↑ Nrf2 phosphorylation. ↑ Nrf2 nuclear translocation. |
[90] | |
PKC | N/A | New Zealand white rabbits | ↑ Nrf2 nuclear translocation. | [91] | |
PERK | N/A | Mouse embryonic fibroblasts | Dissociates Nrf2 from Keap1 by phosphorylation of Nrf2. | [79] | |
Autophagy-substrate proteins | Sequestosome 1 (p62) | N/A | Human aortic smooth muscle cells | Competes with Nrf2 to bind with Keap1. | [88] |
Synthetic compounds | |||||
Synthetic triterpenoids | Bradoxolone-methyl (CDDO-Me) | 25–50 mg/day for 52 weeks | Phase 2 clinical on diabetic nephropathy | ↑ electrophilic modification of Keap1-Cys-151. | [47,84] |
Synthetic triterpenoids | RTA-408 (omaveloxolone) | 1% ophthalmic suspension for twice a day for 14 days | Phase 2 clinical trial on inflammation and pain following ocular surgery | ↑ electrophilic modification of Keap1-Cys-151. | [47,83] |
Synthetic lignans | LGM2605 (Secoisolariciresinol diglucoside) | 50 µM | Murine peritoneal macrophages derived from C57BL/6J mice | ↑ mRNA expression of GST and redoxin reductase 1. | [166] |
Abbreviations—HaCaT: human skin keratinocytes; ARPE-19: human retinal pigment epithelial cell line; HT22: mouse hippocampal neuronal cell line; LLC PK1: porcine renal epithelial proximal tubule cell line; NRK-52E: rat kidney epithelial cell line; IEC-6: intestinal epithelial cell line; HK-2: human renal tubular epithelial cell line; HL-7702/ L-02: human liver cell line; MRC5: human embryonic lung cell line; HTR8/Sveo: extravillous trophoblast cell line; HEK 293T: human embryonic kidney 293T cell line; HT22: mouse neuronal cell line; H9C2: rat myoblast cell line: TM4: mouse Sertoli cell line; T2DM mice: type 2 diabetes mellitus mice; BJ: human foreskin fibroblast cell line; WT: wild type; KO: knock-out; JB6 P+: mouse skin cells; APP/PSI: ARTE1; GCLM: glutamate-cysteine ligase modifier; GSH: glutathione; CAT: catalase; SOD; superoxide dismutase; GPx: glutathione peroxidase; ARE: antioxidant response element; ERK: extracellular signal-regulated protein kinase; GSK-3β: glycogen synthase kinase 3; Akt: protein kinase B; GR: glutathione reductase; NQO-1: NAD(P)H quinone dehydrogenase 1; HO-1: heme oxygenase 1; GST- glutathione S-transferase; Ser212: serine residue 212; Ser408: serine residue; Ser558: serine residue 558; Ser577: serine residue 577; Thre559: threonine residue 559; PI3K: phosphorylation of phosphatidylinositol 3-kinase; JNK: N-terminal kinase; AMPK: 5′ adenosine monophosphate-activated protein kinase; PKC: protein kinase C; PERK: protein kinase-like endoplasmic reticulum-resident kinase; p62: sequestosome 1; Keap1: Kelch-like ECH-associated protein 1; Nrf2: Nuclear factor erythroid 2 p45 (NF-E2)-related factor; ↑ increase; ↓ decrease.